Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors

Medicinal Chemistry Research

Volumn 20, Issue 9, 2011, Pages 1556-1565

  Singh, Shalini ^a   Singh, Sarika ^a   Shukla, Poonam ^b  

^a BAREILLY COLLEGE   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

HIV 1 protease inhibitors; Molecular fragments; N Aryl oxazolidinone 5 carboxamides; QSAR; Quantum chemical; Topological finger print

Indexed keywords

AMIDE; HUMAN IMMUNODEFICIENCY VIRUS 1 PROTEINASE INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; N ARYL OXAZOLIDINONE 5 CARBOXAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG ACTIVITY; MULTIPLE LINEAR REGRESSION ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY;

EID: 84856223857     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9416-0     Document Type: Conference Paper

References (35)

1. Ali A, Reddy GS, Cao H, Anjum SG, Nalam MN, Schiffer CA, Rana TM (2006) Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands. J Med Chem 49:7342-7356 (Pubitemid 44913395)
2. Allinger NL (1977) Conformational analysis 130 MM2 A hydrocarbon force field utilizing V1 and V2 torsional terms. J Am Chem Soc 99:8127
3. Appelt K (1993) Crystal structure of HIV-1 protease-inhibitor complexes. Perspect Drug Discov Des 1:23
4. Babine RE, Bender SL (1997) Molecular recognition of proteinminus signligand complexes: Applications to drug design. Chem Rev 97:1359
5. Boehme RE, Borthwick AD, Wyatt PG (1995) Antiviral agents. Annu Rep Med Chem 30:139
6. Burkert U, Allinger NL (1982) Molecular mechanics ACS monograph 177. Am Chem Soc, Washington, DC
7. Carhart RE, Smith DH, Ventakataraghavan R (1985) Atom pairs as molecular features in structure-activity studies: Definition and applications. J Chem Inf Comput Sci 25:64-73
8. Charterjee S, Hadi AS, Price B (2000) Regression analysis by examples, 3rd edn. Wiley, New York
9. De Clercq E (1995) Antiviral therapy for human immunodeficiency virus infections. J Clin Microbiol Rev 8:200-239
10. HyperCube Inc (2006) HyperChem release7.52 for windows Florida Science and Technology Park, USA
11. Irby RB, Yeatman TJ (2000) Role of src expression and activation in human cancer. Oncogene 19:5636
12. Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE (2003) Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 134:221
13. Ivanciuc O, Ivanciuc T, Balaban Alexandru T (2002) QSAR models for the dermal penetration of polycyclic aromatic hydrocarbons. Internet Electron J Mol Des 1:566
14. Jacobsen H, Yasargil K, Winslow DL, Craig JC, Krohn A, Duncan IB, Mous J (1995) Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology 206:527
15. Mitsuya H, Erickson J (1999) Discovery and development of antiretroviral therapeutics for HIV infection. In: Merigan TC, Bartlett JG, Bolognesi D (eds) Text book of AIDS medicine. Williams & Wilkins, Baltimore, p 751
16. Montgomery Douglas C, Peck Elizabeth A, Vining Geoffrey G (2006) Introduction to linear regression analysis, 4th edn. Wiley, New York
17. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, Chopp M, Cheresh DA (2001) Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7:222
18. Singh S (2009) Comparative QSAR studies on the novel series of thiazolones and tetrazole derivatives as HCV NS5B polymerase allosteric inhibitors. Lett Drug Des Discov 6:286-297
19. Singh S, Khadikar Padmakar V, Scozzafava A, Supuran Claudiu T (2009) QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. J Enzym Inhib Med Chem 24: 337-349
20. Stewart JJP (2007) The Mopac program is available from http://www. openmopac.net/
21. Summay JM, Gallick GE (2003) Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22:337
22. Susva M, Missbach M, Green J (2000) Src inhibitors: Drugs for the treatment of osteoporosis, cancer or both? Trends Pharmacol Sci 21:489
23. Talamonti MS, Roh MS, Curely SA, Gallick GE (1993) Increase in activity and level of pp60γ-src in progressive stages of human colorectal cancer. J Clin Invest 91:53
24. Talete srl (2007) DRAGON Plus for windows software for molecular descriptor Calculations Version 5.5-http://www.talete.mi.it/
25. Tarko L (2004) A procedure for virtual fragmentation of molecules into functional groups. ARKIVOC xiv:74-82 (Pubitemid 39363907)
26. Tarko L (2005) Calcule QSPR/QSAR cu ajutorul programului PRECLAV. Rev Chim (Bucuresti) 56:639
27. Tarko L (2007) QSAR studies regarding the inhibition of the carbonic anhydrase by the sulfonamides containing a picolinoyl. Group Rev Chim (Bucuresti) 58:191
28. Tarko L (2008) The PRECLAV v.0809 program is available from the Center of Organic Chemistry (CCO), Romanian Academy, Bucharest
29. Tarko L (2008b) Aromatic molecular zones and fragments. ARIKIVOC xi:24-45
30. Tarko L, Supuran Claudiu T (2007) QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides. Bioorg Med Chem 15:5666-5671 (Pubitemid 47049801)
31. Tarko L, Lupescu I, Groposila-Constantinescu D (2005) Sweetness power QSARs by PRECLAV software. ARKIVOC X:254
32. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113:885
33. Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, Bast Robert C, Mills Gordon B, Gallick Gary E (2003) Activated Src protein tyrosine kinase is overexpressed in latestage human ovarian cancers. Gynecol Oncol 88:73-79 (Pubitemid 36062670)
34. Wlodawer A, Ericson JW (1993) Structure-based inhibitors of HIV-1 protease. Annu Rev Biochem 62:543
35. Yeatman T (2004) A renaissance for SRC. J Nat Rev 4:470